(Q69976418)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3936081%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

title

Clinical and biochemical effects of citalopram, a selective 5-HT reuptake inhibitor--a dose-response study in depressed patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3936081%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3936081%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

author name string

L Bjerkenstedt

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3936081%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

G Edman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3936081%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

L Hagenfeldt

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3936081%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

G Sedvall

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3936081%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

F A Wiesel

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3936081%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

publication date

1 January 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3936081%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3936081%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

volume

87

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3936081%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3936081%20AND%20SRC:MED&resulttype=core&format=json

7 October 2019

page(s)

253-259

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:3936081%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00432703

7 October 2019

exact match

0 references

cites work

AMINE UPTAKE INHIBITORS: CRITERIA OF SELECTIVITY

1 reference

12 December 2020

Alaproclate a novel antidepressant? A biochemical and clinical comparison with zimeldine

1 reference

12 December 2020

Citalopram versus mianserin. A controlled, double-blind trial in depressed patients

1 reference

12 December 2020

Serotoninergic modulation of mesolimbic and frontal cortical dopamine neurons

1 reference

12 December 2020

Relationship between clinical effects, serum drug concentration and serotonin uptake inhibition in depressed patients treated with citalopram. A double-blind comparison of three dose levels

1 reference

12 December 2020

Effect of antidepressant drugs on accumulation and disappearance of monoamines formed in vivo from labelled precursors in mouse brain.

1 reference

12 December 2020

1 reference

12 December 2020

Correlation of Subjective Side Effects with Plasma Concentrations of Nortriptyline

1 reference

12 December 2020

Relevance of tryptophan and tyrosine availability in endogenous and 'non-endogenous' depressives treated with imipramine or clomipramine

1 reference

12 December 2020

Concentrations of 5-hydroxyindolylacetic acid and homovanillic acid in the cerebrospinal fluid of the dog before and during treatment with probenecid.

1 reference

12 December 2020

Effect of chronic lithium treatment on monoamine metabolism in rat brain

1 reference

12 December 2020

Transport of metabolic substrates through the blood-brain barrier.

1 reference

12 December 2020

Intensification of the central serotoninergic processes as a possible determinant of the thymoleptic effect

1 reference

12 December 2020

EVIDENCE FOR THE EXISTENCE OF MONOAMINE NEURONS IN THE CENTRAL NERVOUS SYSTEM. IV. DISTRIBUTION OF MONOAMINE NERVE TERMINALS IN THE CENTRAL NERVOUS SYSTEM

1 reference

12 December 2020

Simultaneous determination of the three major monoamine metabolites in brain tissue and body fluids by a mass fragmentographic method.

1 reference

12 December 2020

Lithium-induced changes in plasma amino acid levels during treatment of affective disorders.

1 reference

12 December 2020

Brain Serotonin Content: Physiological Regulation by Plasma Neutral Amino Acids

1 reference

12 December 2020

Comparative animal studies on cardiovascular toxicity of tri- and tetracyclic antidepressants and citalopram; relation to drug plasma levels.

1 reference

12 December 2020

Evidence for the existence of a raphe projection to the substantia nigra in rat

1 reference

12 December 2020

Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects

1 reference

12 December 2020

Tryptophan and tyrosine ratios to neutral amino acids in endogenous depression. Relation to antidepressant response to amitriptyline and lithium + L-tryptophan

1 reference

12 December 2020

Time Course for Effects of Sulpiride and Chlorpromazine on Monoamine Metabolite and Prolactin Levels in Cerebrospinal Fluid from Schizophrenic Patients

1 reference

12 December 2020

Effect of a selective 5-HT uptake inhibitor--Lu 10-171--on rat brain 5-HT turnover

1 reference

12 December 2020

A New Depression Scale Designed to be Sensitive to Change

1 reference

12 December 2020

Relationship between plasma ratio of tryptophan to competing amino acids and the response to L-tryptophan treatment in endogenously depressed patients

1 reference

12 December 2020

A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility

1 reference

12 December 2020

Effect of a specific 5-HT uptake inhibitor, citalopram (Lu 10-171), on 3H-5-HT uptake in rat brain synaptosomes in vitro

1 reference

12 December 2020

Neutral amino acids in the brain: changes in response to food ingestion

1 reference

12 December 2020

A pharmacokinetic approach to the treatment of depression

1 reference

12 December 2020

Studies on acute toxicity and drug levels of citalopram in the dog

1 reference

12 December 2020

Citalopram, a selective serotonin reuptake inhibitor: clinical antidepressive and long-term effect--a phase II study.

1 reference

12 December 2020

Pharmacology of a new phthaline (Lu 10-171), with specific 5-HT uptake inhibiting properties

1 reference

12 December 2020

Studies in the classification of affective disorders. The relationship between anxiety states and depressive illnesses. II

1 reference

12 December 2020

Preliminary studies with citalopram (LU 10-171), a specific 5-HT-reuptake inhibitor, as antidepressant

1 reference

12 December 2020

Neurochemical characterization of a new potent and selective serotonin uptake inhibitor: Lu 10-171

1 reference

12 December 2020

Relationships between stress and brain 5-hydroxytryptamine and their possible significance in affective disorders

1 reference

12 December 2020

Effects of short- and long-term neuroleptic treatment on brain serotonin synthesis and turnover: focus on the serotonin hypothesis of schizophrenia

1 reference

12 December 2020

Initial, clinical trial of a new, specific 5-HT reuptake inhibitor, citalopram (Lu 10-171).

1 reference

12 December 2020

High-affinity [3H]imipramine binding in rat hypothalamus: association with uptake of serotonin but not of norepinephrine

1 reference

12 December 2020

Citalopram — Pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity

1 reference

12 December 2020

Citalopram--a specific 5-HT-reuptake inhibitor--as an antidepressant drug: a phase II multicentre trail

1 reference

12 December 2020